CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Phase II Study of Pemetrexed as a Salvage Chemotherapy for Thymidylate Synthase–Low Squamous Cell Lung Cancer
Mihong Choi, Heung Tae Kim, Ji-Youn Han, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Hye Jin Won, Jin Soo Lee, Youngjoo Lee
Cancer Research and Treatment. 2021;53(1):87-92.   Published online 2020 August 13    DOI:

Excel Download

Phase II Study of Pemetrexed as a Salvage Chemotherapy for Thymidylate Synthase–Low Squamous Cell Lung Cancer
Cancer Research and Treatment. 2021;53(1):87-92   Crossref logo
Link1 Link2 Link3

The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysis
BMC Cancer. 2014;14(1):   Crossref logo
Link1 Link2 Link3 Link4

The Pemetrexed-Containing Treatments in the Non-small Cell Lung Cancer, Is -/Low Thymidylate Synthase Expression Better than +/High Thymidylate Synthase Expression? A Meta-analysis
Chest. 2014;145(3):349A   Crossref logo
Link1 Link2

Unresectable non metastatic squamous cell carcinoma of the lung: Phase II study of radical radiotherapy and combined chemotherapy
Lung Cancer. 1985;1(3-4):82   Crossref logo
Link1 Link2

Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study
Cancer Chemotherapy and Pharmacology. 2013;72(2):445-452   Crossref logo
Link1 Link2 Link3

Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis
Cancer Chemotherapy and Pharmacology. 2013;72(5):1125-1132   Crossref logo
Link1 Link2 Link3

PROCLAIM: A Phase III Study of Pemetrexed, Cisplatin, and Radiation Therapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiation Therapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Locally Advanced Stage III Non–Small-Cell Lung Cancer of Other than Predominantly Squamous Cell Histology
Clinical Lung Cancer. 2009;10(3):193-198   Crossref logo
Link1 Link2

44 Review of the pemetrexed–cisplatin chemotherapy in non-squamous non-small cell lung cancer in Royal Shrewsbury Hospital
Lung Cancer. 2013;79:S15   Crossref logo
Link1 Link2

Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression
Chemotherapy. 2012;58(4):313-320   Crossref logo
Link1 Link2

Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902
Cancer Chemotherapy and Pharmacology. 2014;74(6):1149-1157   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.